Skip to content


Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol

  • David Pettitt1, 2,
  • Zeeshaan Arshad3, 4Email author,
  • Benjamin Davies17,
  • James Smith1, 5,
  • Anna French1,
  • Doug Cole6,
  • Kim Bure7,
  • Sue Dopson8,
  • David DiGiusto9,
  • Jeff Karp10, 11, 12,
  • Brock Reeve13,
  • Richard Barker8,
  • Georg Holländer2, 14 and
  • David Brindley1, 2, 8, 13, 15, 16
Systematic Reviews20176:120

Received: 1 September 2016

Accepted: 9 June 2017

Published: 26 June 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting

Original Submission
1 Sep 2016 Submitted Original manuscript
24 Mar 2017 Reviewed Reviewer Report - Andrew Webster
12 May 2017 Author responded Author comments - David Pettitt
Resubmission - Version 2
12 May 2017 Submitted Manuscript version 2
9 Jun 2017 Editorially accepted
26 Jun 2017 Article published 10.1186/s13643-017-0517-4

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting

You can find further information about the peer review system here.

Authors’ Affiliations

The Oxford – UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, UK
Department of Paediatrics, University of Oxford, Oxford, UK
University of St. Andrews School of Medicine, University of St. Andrews, St. Andrews, UK
, Glenrothes, UK
Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
Flagship Ventures, Cambridge, USA
Sartorius Stedim, Göttingen, Germany
Said Business School, University of Oxford, Oxford, UK
Division of Cell Transplantation and Regenerative Medicine, University of Stanford, Stanford, USA
Harvard Medical School, Harvard University, Boston, USA
Brigham and Women’s Hospital, Boston, USA
Harvard-MIT Division of Health Sciences and Technology, Cambridge, USA
Harvard Stem Cell Institute, Cambridge, USA
Department of Biomedicine, University of Basel and Basel University Children’s Hospital, Basel, Switzerland
Centre for Behavioral Medicine, UCL School of Pharmacy, University College London, London, UK
USCF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI), Stanford, USA
Orthopedic Surgery Departement, University of Cambridge, Cambridge, UK